cetylpyridinium chloride anhydrous has been researched along with Anorexia Nervosa in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fazeli, PK; Goldstein, M; Klibanski, A; Miller, KK; Misra, M | 1 |
| Breggia, A; Faje, AT; Fazeli, PK; Katzman, DK; Klibanski, A; Mendes, N; Miller, KK; Misra, M; Rosen, CJ | 1 |
1 trial(s) available for cetylpyridinium chloride anhydrous and Anorexia Nervosa
| Article | Year |
|---|---|
Sclerostin levels and bone turnover markers in adolescents with anorexia nervosa and healthy adolescent girls.
Topics: Adaptor Proteins, Signal Transducing; Adolescent; Anorexia Nervosa; Biomarkers; Body Composition; Body Weight; Bone Density; Bone Morphogenetic Proteins; Bone Remodeling; Case-Control Studies; Estradiol; Female; Genetic Markers; Health; Hormone Replacement Therapy; Humans | 2012 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Anorexia Nervosa
| Article | Year |
|---|---|
Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa.
Topics: Adolescent; Anorexia Nervosa; Area Under Curve; Blood Glucose; Body Composition; Case-Control Studies; Drug Resistance; Female; Fibroblast Growth Factors; Health; Human Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Leptin; Prognosis | 2010 |